ATE109972T1 - Beschichtungsmittel für beständige arzneizubereitungen mit verzögerter wirkstoffabgabe. - Google Patents

Beschichtungsmittel für beständige arzneizubereitungen mit verzögerter wirkstoffabgabe.

Info

Publication number
ATE109972T1
ATE109972T1 AT91102524T AT91102524T ATE109972T1 AT E109972 T1 ATE109972 T1 AT E109972T1 AT 91102524 T AT91102524 T AT 91102524T AT 91102524 T AT91102524 T AT 91102524T AT E109972 T1 ATE109972 T1 AT E109972T1
Authority
AT
Austria
Prior art keywords
glyceryl ester
acid
deca
coating
coating agent
Prior art date
Application number
AT91102524T
Other languages
English (en)
Inventor
Yohko Akiyama
Naoki Nagahara
Minoru Yoshioka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE109972T1 publication Critical patent/ATE109972T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
AT91102524T 1990-02-23 1991-02-21 Beschichtungsmittel für beständige arzneizubereitungen mit verzögerter wirkstoffabgabe. ATE109972T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4282590 1990-02-23

Publications (1)

Publication Number Publication Date
ATE109972T1 true ATE109972T1 (de) 1994-09-15

Family

ID=12646737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91102524T ATE109972T1 (de) 1990-02-23 1991-02-21 Beschichtungsmittel für beständige arzneizubereitungen mit verzögerter wirkstoffabgabe.

Country Status (12)

Country Link
US (1) US5162057A (de)
EP (1) EP0443572B1 (de)
JP (1) JP3078859B2 (de)
KR (1) KR910021236A (de)
AT (1) ATE109972T1 (de)
AU (1) AU642205B2 (de)
CA (1) CA2036906C (de)
DE (1) DE69103438T2 (de)
DK (1) DK0443572T3 (de)
ES (1) ES2057625T3 (de)
NZ (1) NZ237193A (de)
RU (1) RU2072836C1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366753A (en) * 1991-03-29 1994-11-22 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects at low levels of inclusion
CA2145992C (en) * 1992-10-30 1999-01-19 John Keeney Howie Nondigestible fat compositions containing solid polyglycereol ester particles for passive oil loss control
US5288318A (en) * 1993-07-01 1994-02-22 The United States Of America As Represented By The Secretary Of The Army Cellulose acetate and starch based biodegradable injection molded plastics compositions and methods of manufacture
JPH07112940A (ja) * 1993-08-26 1995-05-02 Takeda Chem Ind Ltd 徐放性非経口投与製剤およびその製造方法
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5478501A (en) * 1994-04-07 1995-12-26 The Andrew Jergens Company Bathing composition containing coated cationic polymer
DE4420516C2 (de) * 1994-06-13 1998-10-22 Henkel Kgaa Polyglycerinpolyhydroxystearate
US5494502A (en) * 1994-10-03 1996-02-27 The Chemmark Corporation Asphalt release agent
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
DE19619636A1 (de) * 1996-05-15 1997-11-20 Basf Ag Latent vernetzende wässerige Polyurethandispersionen
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
AU6422798A (en) * 1997-03-25 1998-10-20 Takeda Chemical Industries Ltd. Stabilized urease inhibitor
DE19726264A1 (de) * 1997-06-20 1998-12-24 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung homogener, Monoglyceride und polare oder unpolare Substanzen enthaltender wasserfreier Formulierungen
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
JP3466921B2 (ja) * 1998-06-03 2003-11-17 大塚製薬株式会社 味マスキング医薬製剤
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
CA2372994C (en) * 1999-06-04 2010-03-23 Alza Corporation Implantable gel compositions and method of manufacture
EP1949890A3 (de) 1999-06-04 2011-05-18 ALZA Corporation Implantierbare Gelzusammensetzungen und Herstellungsverfahren dafür
US6251432B1 (en) * 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
FR2816507B1 (fr) 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
IL155959A0 (en) 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
ES2187380A1 (es) * 2001-11-16 2003-06-01 Sanchez Juan Balufo Mejoras introducidas en productos destinados al consumo humano o animal.
EP1490031A1 (de) * 2002-03-07 2004-12-29 Vectura Limited Schnell schmelzende multiteilchen-formulierungen für die orale abgabe
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
JP4312423B2 (ja) * 2002-06-14 2009-08-12 ピジョン株式会社 腸溶性カプセル剤
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
CA2529475C (en) 2003-06-27 2012-08-07 Otsuka Pharmaceutical Co., Ltd. Medicament sustained-release particles and method for preparing the same
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20060240194A1 (en) * 2005-04-26 2006-10-26 Cargill, Incorporated Polyglycerol fatty acid ester composition and coating
TWI274889B (en) * 2005-10-06 2007-03-01 Elan Microelectronics Corp Resistive touch screen measurement system
JP5069417B2 (ja) * 2006-03-20 2012-11-07 三菱商事フードテック株式会社 フィルムコーティング層とフィルムコーティング製品及びその製造方法
EP2050456A4 (de) * 2006-08-09 2013-01-23 Mitsubishi Tanabe Pharma Corp Tablette
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
US8227399B2 (en) * 2010-02-12 2012-07-24 Evonik Goldschmidt Gmbh Polyglycerol esters and their use
JP5226097B2 (ja) * 2011-03-30 2013-07-03 株式会社ファンケル サプリメントを内包する蓋体とサプリメント分散媒を充填したボトルからなるボトル入り飲料
JP5308583B1 (ja) * 2012-03-29 2013-10-09 株式会社ファンケル ボトル飲料
JP7039197B2 (ja) * 2017-06-30 2022-03-22 小林製薬株式会社 Ｓ／ｏ型サスペンション及びその製造方法
BR112021002157A2 (pt) * 2018-10-22 2021-05-04 Ioi Oleo Gmbh material de revestimento para uso em um método de revestimento hot-melt, combinação de material de revestimento e método de revestimento hot-melt

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097144A (en) * 1960-10-14 1963-07-09 Upjohn Co Heat-cured, polymeric, medicinal dosage film coatings containing a polyvinylpyrrolidone copolymer, polyethenoid acid, and polyethylene glycol
US3244596A (en) * 1962-10-18 1966-04-05 Univ Iowa College Of Pharmacy Coated medicinal agents and coating compositions therefor
US3914131A (en) * 1971-08-23 1975-10-21 Emery Industries Inc Useful wax compositions
JPS5966844A (ja) * 1982-10-12 1984-04-16 Riken Vitamin Co Ltd 養魚用生餌飼料組成物
JPS6112632A (ja) * 1984-06-27 1986-01-21 Eisai Co Ltd 脂溶性薬剤含有組成物
JPS6156050A (ja) * 1984-08-23 1986-03-20 Asahi Denka Kogyo Kk 冷凍食品
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.

Also Published As

Publication number Publication date
US5162057A (en) 1992-11-10
DE69103438T2 (de) 1994-11-24
NZ237193A (en) 1994-09-27
RU2072836C1 (ru) 1997-02-10
DE69103438D1 (de) 1994-09-22
KR910021236A (ko) 1991-12-20
ES2057625T3 (es) 1994-10-16
CA2036906A1 (en) 1991-08-24
AU7114691A (en) 1991-09-12
AU642205B2 (en) 1993-10-14
EP0443572A1 (de) 1991-08-28
DK0443572T3 (da) 1994-09-19
JP3078859B2 (ja) 2000-08-21
CA2036906C (en) 2002-01-22
JPH05310599A (ja) 1993-11-22
EP0443572B1 (de) 1994-08-17

Similar Documents

Publication Publication Date Title
ATE109972T1 (de) Beschichtungsmittel für beständige arzneizubereitungen mit verzögerter wirkstoffabgabe.
ATE106239T1 (de) Zubereitungen mit kontrollierter wirkstoffabgabe.
NZ224278A (en) Ibuprofen sustained release tablet and process
IL111519A (en) Sustained release tablets containing acetaminophen and methods for the preparation thereof
DE59209706D1 (de) S(+)-Ibuprofen enthaltende Arzneimittel
ES2153355T3 (es) Procedimiento para la preparacion de microesferas que contienen compuestos biologicamente activos.
HUT62470A (en) Process for producing pharmaceutical composition comprising 4-biphenylacetic acid as active ingredient
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
GB1296505A (de)
HUT55597A (en) Acaricide and insecticide preparation containing halogenized olefines as active agents and process for the production of the active agent
TWI255720B (en) Novel preparation and administration form comprising an acid-labile active compound and process for production thereof
HUT52374A (en) Process for producing pharmaceutical compositions
ES2140467T3 (es) Procedimiento para la obtencion de granulados tensioactivos.
KR960702322A (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent)
HUT52388A (en) Process for producing pharmaceutical compositions comprising unsaturated fatty acids and selenium as active ingredient
HUT61024A (en) Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient
ES2093192T3 (es) Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno.
HUT48192A (en) Process for producing catechol carboxylic acid derivatives and pharmaceuticals comprising such active ingredient
EP0427396A3 (en) Optically active fluorine-containing 3-hydroxybutyric acid esters and process for producing same
HUT44005A (en) Insecticide and acaricide compositions containing esters of carbamic acids as active components and process for producing the active components
HUT45841A (en) Herbicidal compositions comprising 3-amino-2-cyano-acrylic acid ester derivatives as active ingredient and process for producing the active ingredient
JPS5640606A (en) Preparation of stable drug
IL100531A0 (en) Process for the preparation of optically active esters of quinoxalinyloxy-phenoxypropionic acid
HUT47895A (en) Insecticide and acaricide composition containing substituted phenyl-acetic acid ester derivatives as active components and process for producing the active components
HU179068B (en) Herbicide compositions containing esters of carbanilidic acid derivatives and process for producing the active agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee